Steven Cohen’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
Steven Cohen's NTLA Position: Q3 2026 in Review
Steven Cohen sold out of Intellia Therapeutics (NTLA) in Q3 2026, closing a stake of 398,463 shares — an estimated $4.98M sold.
Steven Cohen first reported a position in NTLA in Q2 2020 and held it in 7 quarters. The position peaked at $18.3M in Q2 2020. 312 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.
- Steven Cohen reported no remaining Intellia Therapeutics position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 398,463 Intellia Therapeutics shares in Q3 2026, an estimated $4.98M.
- Steven Cohen first reported a position in Intellia Therapeutics in Q2 2020 and held it in 7 quarters.
- Steven Cohen's Intellia Therapeutics position peaked at $18.3M in Q2 2020.
- 312 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.